PC Pharma Limited - Colombo Stock Exchange

More documents

Recommendations

Info

11. Statutory Declaration Declaration by the Board of Directors Date: 27 th December 2011 We the undersigned, who are named in the Introductory Document as Directors of PC Pharma Limited, hereby declare and confirm that we have read the provisions of the CSE listing rules and of the Companies Act No. 07 of 2007 and any amendments to it relating to the issue of this Introductory Document and those provisions have been complied with. This Introductory Document has been seen and approved by us and we collectively and individually accept full responsibility for the accuracy of the information given and confirm that after making all reasonable enquires and to the best of our knowledge and belief, there are no other facts the omission of which would make any statement herein misleading or inaccurate. Where representations regarding the future performance of PC Pharma Limited have been given in the Introductory Document, such representations have been made after due and careful enquiry of the information available to PC Pharma Limited and making assumptions that are considered to be reasonable at the present point in time in our best judgment. Name Designation Signature Mr. Saheedul Hijiry Mohamed Rishan Chairman (Signed) Mrs. Sithy Sharmila Rishan Director (Signed) Mr. Mushtaq Ahmed Ikram Director (Signed) Mr. Ramasamy Selvaraj Director (Signed) Mr. Prasanna Lakshantha Wijesekara Director (Signed) Mrs. Shanthi Sri Nanda Goonaratne Director (Signed) 46 Introductory Document – PC Pharma Limited
12. Statutory and Other General Information Inspection of Documents The Introductory Document and The Articles of Association of PC Pharma Limited will be available on the website of the CSE (www.cse.lk) and on the Company website (http://www.pcpharma.lk) for a period of not less than 14 days. Reports by Experts Apart from the Independent Auditors Report, this Introductory Document does not include any other reports or statements made by experts. Introductory Document – PC Pharma Limited 47
Page 3:
PC Pharma Limited Introductory Docu
Page 7: Abbreviations CBSL Central Bank of
Page 10 and 11: 5. 5.1 5.2 5.3 5.4 6. 6.1 6.2 7. 7.
Page 12 and 13: Board of Directors Mr. Saheedul Hij
Page 14 and 15: CT Smith Stockbrokers (Pvt) Limited
Page 16 and 17: 3. 3.1 3.2 Overview of the Healthca
Page 18 and 19: Table 3.1: Health Sector Infrastruc
Page 20 and 21: Guidelines are in place making it m
Page 22 and 23: 3.5 pharmaceuticals covering a wide
Page 24 and 25: 4. 4.1 Company Profile Group Overvi
Page 26 and 27: 4.3 Pharmaceutical items of superio
Page 28 and 29: 4.5 The company is also involved in
Page 30 and 31: 4.6 Distribution PC Pharma Limited
Page 32 and 33: 4.7 Financial Highlights Salient ex
Page 34 and 35: 4.8 Key Financial Ratios The key fi
Page 36 and 37: 4.11 4.12 IT Infrastructure The per
Page 38 and 39: 5.2 5.3 Underlying Assumptions on W
Page 40 and 41: Risk associated with the Manufactur
Page 42 and 43: Introductory Document - PC Pharma L
Page 44 and 45: Natasha Antoinette Abeyagoonasekera
Page 46 and 47: 7.2 Share Capital Share Allotments
Page 48 and 49: Distribution of Shareholding Distri
Page 50 and 51: 8.1 Mrs. Shanthi Sri Nanda Goonarat
Page 52 and 53: 8.5 8.6 Director’s Emoluments Emo
Page 54 and 55: 10. Corporate Governance Practices
Page 58 and 59: Audited Financial Statements 48 Int
Page 60 and 61: 50 Introductory Document - PC Pharm
Page 74 and 75: Annexure II - Auditors Report and F
Page 106 and 107:
Interim Financial Statements 96 Int
Page 108 and 109:
98 Introductory Document - PC Pharm
show all

PC Pharma Limited - Colombo Stock Exchange

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?